Abstract.
Objective and design: To investigate the effect of galectin-1 (Gal-1) and −3 (Gal-3) on leukocyte migration and analyze the expression of both galectins in inflammatory cells using a model of rat peritonitis.
Material or Subjects: Sprague-Dawley rats (n = 4 per group).
Treatment: Peritonitis was induced in animals through intraperitoneal injection of carrageenin (1.5 mg/kg) and rat mesenteries were analyzed at different time points (0, 4, 24 and 48h). For pharmacological treatment, rats received intravenous injection of Gal-1 or -3 (3μg/kg) followed by carrageenin.
Methods: Western blotting and immunoelectron microscopy analysis. Statistical analysis was performed using ANOVA followed by Bonferroni test.
Results: Pharmacological treatment with Gal-1, but not Gal-3, inhibited (~50 %) leukocyte recruitment into the peritoneal cavity at 4 h time-point. In this early phase, immunogold staining of mesenteries showed a diminished Gal-3 expression in degranulated mast cells and Gal-1 in transmigrated neutrophils (~20 % reduction compared to intravascular cells). In the later phases (24 and 48h), leukocyte turnover was associated with augmented Gal-1 expression in neutrophils and macrophages and Gal-3 in mast cells and macrophages.
Conclusions: These results point to a balanced expression of cell-associated-Gal-1/Gal-3 and might impact on the development of new therapeutic strategies for inflammatory diseases.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 2 September 2005; returned for revision 28 October 2005; returned for final revision 22 November 2005; accepted by M. Parnham 23 November 2005
Rights and permissions
About this article
Cite this article
Gil, C.D., Cooper, D., Rosignoli, G. et al. Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis. Inflamm. res. 55, 99–107 (2006). https://doi.org/10.1007/s00011-005-0059-4
Issue Date:
DOI: https://doi.org/10.1007/s00011-005-0059-4